GO
Loading...

Cardinal Health Settles Charges Related to Overstating Results

Cardinal Health
Cardinal Health

Cardinal Healthhas agreed to pay $35 million to settle charges that it engaged in nearly a four-year fraudulent revenue and earnings scheme, the U.S. Securities and Exchange Commission said on Thursday.

The SEC complaint alleges that from September 2000 to March 2004 the Ohio-based company engaged in this conduct in order to present a false picture of its operating results.

Cardinal materially overstated its operating revenue, earnings and growth trends in certain earnings releases and filings with the agency, the SEC alleged.

The company did not admit to or deny the SEC's allegations.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Michelle Girard, RBS chief U.S. economist, and Michael Hanson, Bank of America Merrill Lynch, provide their take on interest rates ahead of Fed Chair Janet Yellen's first appearance at Jackson Hole, Wyo. The stock market is more optimistic right now while the bond market is more nervous about the longer run, says Hanson.

  • Michelle Girard, RBS chief U.S. economist, and Michael Hanson, Bank of America Merrill Lynch, share their thoughts on the Fed's easy money policy.

  • Jim Cramer talks with Phil Rykhoek, the president and CEO of Denbury Resources to find out about his company's prospects.